Demand is soaring for a new vaccine designed to protect older adults from the painful rash known as shingles.
Shingrix was approved by the FDA last fall and became widely available at the beginning of the year.
This vaccine is more effective and long-lasting--- leading to high demand and waiting lists.
The CDC expects the shortages and shipping delays to continue through 2018.
